Literature DB >> 32302552

Nitrogen Metabolism in Cancer and Immunity.

Kiran Kurmi1, Marcia C Haigis2.   

Abstract

As one of the fundamental requirements for cell growth and proliferation, nitrogen acquisition and utilization must be tightly regulated. Nitrogen can be generated from amino acids (AAs) and utilized for biosynthetic processes through transamination and deamination reactions. Importantly, limitations of nitrogen availability in cells can disrupt the synthesis of proteins, nucleic acids, and other important nitrogen-containing compounds. Rewiring cellular metabolism to support anabolic processes is a feature common to both cancer and proliferating immune cells. In this review, we discuss how nitrogen is utilized in biosynthetic pathways and highlight different metabolic and oncogenic programs that alter the flow of nitrogen to sustain biomass production and growth, an important emerging feature of cancer and immune cell proliferation.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  T cells; ammonia; cancer cells; nitrogen metabolism; non-essential amino acids; transaminases; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32302552      PMCID: PMC7386658          DOI: 10.1016/j.tcb.2020.02.005

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  158 in total

1.  The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Authors:  Jiangbin Ye; Monika Kumanova; Lori S Hart; Kelly Sloane; Haiyan Zhang; Diego N De Panis; Ekaterina Bobrovnikova-Marjon; J Alan Diehl; David Ron; Constantinos Koumenis
Journal:  EMBO J       Date:  2010-05-14       Impact factor: 11.598

Review 2.  Molecular basis and current strategies of therapeutic arginine depletion for cancer.

Authors:  Livingstone Fultang; Ashley Vardon; Carmela De Santo; Francis Mussai
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

Review 3.  Nutrient scavenging in cancer.

Authors:  Brendan T Finicle; Vaishali Jayashankar; Aimee L Edinger
Journal:  Nat Rev Cancer       Date:  2018-10       Impact factor: 60.716

Review 4.  Ammonium metabolism in humans.

Authors:  Maria M Adeva; Gema Souto; Natalia Blanco; Cristóbal Donapetry
Journal:  Metabolism       Date:  2012-08-24       Impact factor: 8.694

5.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.

Authors:  Ainara Elorza; Inés Soro-Arnáiz; Florinda Meléndez-Rodríguez; Victoria Rodríguez-Vaello; Glenn Marsboom; Guillermo de Cárcer; Bárbara Acosta-Iborra; Lucas Albacete-Albacete; Angel Ordóñez; Leticia Serrano-Oviedo; Jose Miguel Giménez-Bachs; Alicia Vara-Vega; Antonio Salinas; Ricardo Sánchez-Prieto; Rafael Martín del Río; Francisco Sánchez-Madrid; Marcos Malumbres; Manuel O Landázuri; Julián Aragonés
Journal:  Mol Cell       Date:  2012-10-25       Impact factor: 17.970

6.  mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient.

Authors:  Gregory A Wyant; Monther Abu-Remaileh; Rachel L Wolfson; Walter W Chen; Elizaveta Freinkman; Laura V Danai; Matthew G Vander Heiden; David M Sabatini
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

7.  Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition.

Authors:  Alexander Muir; Laura V Danai; Dan Y Gui; Chiara Y Waingarten; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

8.  Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.

Authors:  Luika A Timmerman; Thomas Holton; Mariia Yuneva; Raymond J Louie; Mercè Padró; Anneleen Daemen; Min Hu; Denise A Chan; Stephen P Ethier; Laura J van 't Veer; Kornelia Polyak; Frank McCormick; Joe W Gray
Journal:  Cancer Cell       Date:  2013-10-03       Impact factor: 31.743

9.  ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.

Authors:  M van Geldermalsen; Q Wang; R Nagarajah; A D Marshall; A Thoeng; D Gao; W Ritchie; Y Feng; C G Bailey; N Deng; K Harvey; J M Beith; C I Selinger; S A O'Toole; J E J Rasko; J Holst
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

10.  Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.

Authors:  Oliver D K Maddocks; Celia R Berkers; Susan M Mason; Liang Zheng; Karen Blyth; Eyal Gottlieb; Karen H Vousden
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

View more
  18 in total

Review 1.  Metabolic regulation of skeletal cell fate and function in physiology and disease.

Authors:  Nick van Gastel; Geert Carmeliet
Journal:  Nat Metab       Date:  2021-01-04

2.  Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.

Authors:  Clemens P Spielvogel; Stefan Stoiber; Laszlo Papp; Denis Krajnc; Marko Grahovac; Elisabeth Gurnhofer; Karolina Trachtova; Vojtech Bystry; Asha Leisser; Bernhard Jank; Julia Schnoell; Lorenz Kadletz; Gregor Heiduschka; Thomas Beyer; Marcus Hacker; Lukas Kenner; Alexander R Haug
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-26       Impact factor: 10.057

Review 3.  Harnessing metabolic dependencies in pancreatic cancers.

Authors:  Joel Encarnación-Rosado; Alec C Kimmelman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-19       Impact factor: 46.802

Review 4.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04

5.  Study of the metabolic alterations in patulin-induced neoplastic transformation in normal intestinal cells.

Authors:  Neha Singh; Gaurav Sharma; Indra Dev; Sanjeev K Shukla; Kausar Mahmood Ansari
Journal:  Toxicol Res (Camb)       Date:  2021-05-20       Impact factor: 3.524

Review 6.  Metabolic interventions: A new insight into the cancer immunotherapy.

Authors:  Tao Yu; Tianhan Dong; Haniyeh Eyvani; Yuanzhang Fang; Xiyu Wang; Xinna Zhang; Xiongbin Lu
Journal:  Arch Biochem Biophys       Date:  2020-11-02       Impact factor: 4.013

7.  Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.

Authors:  Teng-Fei Yin; Dong-Yan Zhao; Yuan-Chen Zhou; Qian-Qian Wang; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

8.  Exploring the Mechanism of Scutellaria baicalensis Georgi Efficacy against Oral Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fanfan Hou; Yang Liu; YaHsin Cheng; Ni Zhang; Wenpeng Yan; Fang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

Review 9.  Designing Relevant Preclinical Rodent Models for Studying Links Between Nutrition, Obesity, Metabolism, and Cancer.

Authors:  Elaine M Glenny; Michael F Coleman; Erin D Giles; Elizabeth A Wellberg; Stephen D Hursting
Journal:  Annu Rev Nutr       Date:  2021-08-06       Impact factor: 11.848

10.  Identification of Differentially-Methylated Genes and Pathways in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage.

Authors:  Bong Jun Kim; Dong Hyuk Youn; In Bok Chang; Keunsoo Kang; Jin Pyeong Jeon
Journal:  J Korean Neurosurg Soc       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.